4.5 Article

Strain engineering and bioprocessing strategies for biobased production of porphobilinogen in Escherichia coli

期刊

BIORESOURCES AND BIOPROCESSING
卷 8, 期 1, 页码 -

出版社

SPRINGER HEIDELBERG
DOI: 10.1186/s40643-021-00482-3

关键词

Escherichia coli; Glycerol; Glyoxylate shunt; Porphobilinogen (PBG); Strain engineering; Succinyl-CoA; Tricarboxylic acid (TCA) cycle

资金

  1. Government of Canada grant: Natural Sciences and Engineering Research Council (NSERC) Discovery grant [RGPIN-2019-04611]

向作者/读者索取更多资源

Strain engineering and bioprocessing strategies were utilized to produce porphobilinogen (PBG) using Escherichia coli as the cell factory. By implementing non-native pathways, directing carbon flux, and utilizing CRISPRi technology for genetic regulation, high PBG titers were achieved with improved stability and accumulation. This study identified potential factors limiting PBG production and demonstrated effective metabolic engineering approaches for enhancing biobased PBG production.
Strain engineering and bioprocessing strategies were applied for biobased production of porphobilinogen (PBG) using Escherichia coli as the cell factory. The non-native Shemin/C4 pathway was first implemented by heterologous expression of hemA from Rhodopseudomonas spheroids to supply carbon flux from the natural tricarboxylic acid (TCA) pathways for PBG biosynthesis via succinyl-CoA. Metabolic strategies were then applied for carbon flux direction from the TCA pathways to the C4 pathway. To promote PBG stability and accumulation, Clustered Regularly Interspersed Short Palindromic Repeats interference (CRISPRi) was applied to repress hemC expression and, therefore, reduce carbon flowthrough toward porphyrin biosynthesis with minimal impact to cell physiology. To further enhance PBG biosynthesis and accumulation under the hemC-repressed genetic background, we further heterologously expressed native E. coli hemB. Using these engineered E. coli strains for bioreactor cultivation based on similar to 30 g L-1 glycerol, we achieved high PBG titers up to 209 mg L-1, representing 1.73% of the theoretical PBG yield, with improved PBG stability and accumulation. Potential biochemical, genetic, and metabolic factors limiting PBG production were systematically identified for characterization.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据